Pronto disponible para inscripción
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

Radiation Therapy and Thymus Function in Young Women with Breast Cancer - Clinical Trial

¿Cuál es el Propósito de este estudio?

This study includes people who may or may not receive radiation therapy as part of their normal medical care. The radiation treatment is not part of the research and is the usual treatment decided by their doctors.

People who receive radiation therapy will give small blood samples before starting radiation, at the end of radiation, and about six months later. People who do not receive radiation therapy will give blood samples after surgery and again about eight months later.

The blood samples will only be used for research. They will help researchers learn more about how treatment affects the body, but the results will not be used to make decisions about a participant's medical care.

¿Cuál es la Condición que se está estudiando?

cáncer de mama

¿Quién puede participar en el Estudio?

People can join this study if they are women between 18 and 50 years old who are having surgery for breast cancer. The surgery may be a mastectomy, which removes the breast, or a breast conserving surgery that removes only the cancer and a small amount of surrounding tissue. Women with any type of breast cancer may be eligible to participate.

Grupo etario
Adultos

¿Qué Implica?

The purpose of this study is to collect blood samples from young women with breast cancer. Researchers want to learn how radiation therapy and other breast cancer treatments affect a part of the body called the thymus gland, which helps the immune system work properly. By studying these blood samples, researchers hope to better understand how cancer treatments may change the immune system and help improve care for future patients.

Detalles del Estudio

Título Completo
Off-Target Effects of Breast Cancer Adjuvant Radiation Therapy on Thymus Function in Young Women
Investigador Principal
Susan McDuff, MD, PhD
Especialista en oncología radioterápica
Número de Protocolo
IRB: PRO00120784
NCT: NCT07725172
ClinicalTrials.gov
Estado de inscripción
Pronto disponible para inscripción
Apoye la investigación de Duke Health o rinda homenaje a un ser querido con un regalo conmemorativo.
Contribuya a Duke Health